Safety and efficacy of sequential local ablative therapy and peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms and high tumor load; An analysis of 50 sequential patients

Abstract

Pretreated patients with symptomatic neuroendocrine neoplasms in stadium 4 with high tumor load are challenging to treat. Peptide receptor radionuclide therapy and local ablative therapies have shown to induce remissions. However, there are sparse data on sequential application of these therapies.